|
Market Closed -
Nasdaq
16:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 29.05 USD | -6.89% |
|
+8.64% | -42.63% |
| Market Cap | 2.25B 2B 1.84B 1.68B 3.15B 213B 3.2B 22.26B 8.76B 112B 8.44B 8.26B 352B | P/E 2026 * |
-4.99x | P/E 2027 * | -7.38x |
|---|---|---|---|---|---|
| Enterprise Value | 2.3B 2.05B 1.89B 1.72B 3.23B 218B 3.28B 22.81B 8.98B 115B 8.64B 8.46B 361B | EV / Sales 2026 * |
92.8x | EV / Sales 2027 * | 9.83x |
| Free-Float |
98.99% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VERA | Delayed | |
CBOE
| VERA | Real-time |
Last Transcript: Vera Therapeutics, Inc.
| 1 day | -6.89% | ||
| 1 week | +8.64% | ||
| Current month | -10.03% | ||
| 1 month | -15.18% | ||
| 3 months | -21.85% | ||
| 6 months | -27.48% | ||
| Current year | -42.63% |
| 1 week | 27.5 |  | 31.84 |
| 1 month | 26.38 | | 36.5 |
| Current year | 26.38 | | 50.84 |
| 1 year | 23.05 | | 56.05 |
| 3 years | 9.24 | | 56.05 |
| 5 years | 5.2 | | 56.05 |
| 10 years | 5.2 | | 56.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marshall Fordyce
CEO | Chief Executive Officer | 52 | 2016-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 41 | 2021-07-11 |
Amit Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Marshall Fordyce
BRD | Director/Board Member | 52 | 2016-04-30 |
Andrew Cheng
BRD | Director/Board Member | 59 | 2017-01-31 |
Beth Seidenberg
BRD | Director/Board Member | 69 | 2016-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Founder | 55,500 | 0.0770% | ||
| 9/11/26 | Exercice | Controller/Auditor | 10,000 | 0.0139% | ||
| 9/2/26 | Exercice | Founder | 55,500 | 0.0770% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.89% | +8.64% | -4.22% | +195.22% | 2.25B | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +4.99% | +7.61% | +72.82% | 55.2B | |
| +0.74% | +7.31% | +12.50% | +88.71% | 52.79B | |
| +0.61% | +6.22% | +27.28% | +50.97% | 45.53B | |
| -1.08% | +8.76% | +21.07% | +131.38% | 43.94B | |
| -3.39% | -3.01% | +250.89% | +571.04% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +6.97% | +38.37% | +28.59% | 23.51B | |
| Average | -2.33% | +4.75% | +43.18% | +126.06% | 39.09B | |
| Weighted average by Cap. | -1.72% | +3.51% | +46.76% | +122.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24.83M 22.13M 20.36M 18.53M 34.77M 2.35B 35.39M 246M 96.79M 1.23B 93.16M 91.21M 3.89B | 234M 208M 192M 174M 327M 22.16B 333M 2.31B 911M 11.62B 877M 859M 36.63B |
| Net income | -454M -405M -372M -339M -636M -43.06B -647M -4.5B -1.77B -22.58B -1.7B -1.67B -71.18B | -326M -291M -268M -244M -457M -30.95B -465M -3.23B -1.27B -16.23B -1.22B -1.2B -51.16B |
| Net Debt | 54.8M 48.85M 44.94M 40.89M 76.75M 5.2B 78.11M 543M 214M 2.72B 206M 201M 8.59B | 49.16M 43.82M 40.32M 36.68M 68.85M 4.66B 70.07M 487M 192M 2.44B 184M 181M 7.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | US$29.05 | -6.89% | 2,544,833 |
| 26-10-21 | US$31.20 | +3.79% | 2,083,728 |
| 26-10-20 | US$30.06 | +3.94% | 1,189,470 |
| 26-10-19 | US$28.92 | +3.73% | 1,269,409 |
| 26-10-16 | US$27.88 | -2.42% | 1,294,581 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VERA Stock
Select your edition
All financial news and data tailored to specific country editions
